Division of Endoscopy, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Department of Biostatistics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Surg Endosc. 2021 Oct;35(10):5497-5507. doi: 10.1007/s00464-020-08042-0. Epub 2020 Oct 1.
Although colorectal endoscopic submucosal dissection (ESD) has become a standardized procedure worldwide, the difficulty of the procedure is well known. However, there have been no studies assessing the causes of treatment interruption. The present study aimed to evaluate the factors involved in the interruption of colorectal ESD.
We retrospectively analyzed 1116 consecutive superficial colorectal neoplasms of 1012 patients who were treated with ESD between August 2008 and September 2018. The clinicopathological characteristics and treatment outcomes were analyzed.
Interrupted ESD was reported in 14 lesions (1.3%) of the total study population. Univariate analysis of clinical characteristics indicated that age, 0-I macroscopic-type tumor, and tumor location on the left side colon were risk factors for interruption. Multivariate analysis revealed that 0-I macroscopic-type tumor was the sole preoperative independent risk factor for interruption. Univariate analysis revealed that the presence of muscle-retracting sign (MRS), deep submucosal tumor invasion, and intermediate invasive growth pattern represented the etiology of interruption. Multivariate analysis indicated that MRS can be a sole key sign for the interruption. Additionally, the resectability and curability of 0-I type tumors were significantly inferior to those of predominantly lateral spreading tumors. Observations of 0-I macroscopic-type tumors, MRS, and submucosal deep invasion were significantly more frequent in interrupted cases. Conventional endoscopic images without magnification endoscopy were more associated with interruption than irregular surfaces or Vi pit patterns in cases with 0-I type tumors.
ESD of 0-I type tumors is highly disruptive, and undiagnosable submucosal infiltration can reduce the curability.
尽管结直肠内镜黏膜下剥离术(ESD)已在全球范围内成为一种标准化的手术方式,但该手术的难度众所周知。然而,目前尚无研究评估治疗中断的原因。本研究旨在评估导致结直肠 ESD 中断的因素。
我们回顾性分析了 2008 年 8 月至 2018 年 9 月期间接受 ESD 治疗的 1012 例患者的 1116 例连续浅表性结直肠肿瘤。分析了临床病理特征和治疗结果。
在总研究人群中,有 14 个病变(1.3%)报告了中断的 ESD。对临床特征的单因素分析表明,年龄、0-I 型大体肿瘤和左半结肠肿瘤位置是中断的危险因素。多因素分析显示,0-I 型大体肿瘤是唯一的术前独立中断危险因素。单因素分析显示,回缩肌征(MRS)、黏膜下深层肿瘤浸润和中间浸润生长模式是中断的病因。多因素分析表明,MRS 可以是唯一的关键征象。此外,0-I 型肿瘤的可切除性和可治愈性明显低于主要侧向扩展型肿瘤。在中断病例中,0-I 型大体肿瘤、MRS 和黏膜下深层浸润的观察更为频繁。与 0-I 型肿瘤的不规则表面或 Vi 凹陷模式相比,没有放大内镜的常规内镜图像更与中断相关。
0-I 型肿瘤的 ESD 高度具有破坏性,不可诊断的黏膜下浸润会降低其可治愈性。